Related Experiment Video
Updated: Apr 11, 2026
06:38
Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021
32.8K
Interleukin-34 induces monocytic-like differentiation in leukemia cell lines
Burthia E Booker1, Ryan S Clark2, Samuel T Pellom3
1Department of Biochemistry and Cancer Biology, Meharry Medical College Nashville, TN., USA 37208.
Summary
Interleukin-34 (IL-34) induces differentiation in leukemia cell lines toward monocyte-like cells. This cytokine promotes monocytic maturation and function without affecting cell growth, offering new insights into leukemia treatment.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- Interleukin-34 (IL-34) is a cytokine known to interact with M-CSF receptor and RPTP-ƺ.
- IL-34 promotes monocyte viability, proliferation, and differentiation of bone marrow cells into macrophage progenitors.
- Previous research focused on IL-34's effects on normal hematopoietic and osteoclast progenitors, with its role in cancer largely unexplored.
Purpose of the Study:
- To investigate the biological effects of IL-34 in cancer, specifically its potential to induce differentiation in leukemia cell lines.
- To characterize the differentiation process induced by IL-34 in human leukemic cells, including morphological, functional, and molecular changes.
Main Methods:
- Treatment of U937, HL-60, and THP-1 leukemia cell lines with IL-34.
- Morphological analysis to assess differentiation.
- Flow cytometry to evaluate cell surface marker expression (CD64, CD86, CD11b, CD71, CD14, CD68).
- Functional assays including endocytosis and respiratory burst activity.
- Analysis of signaling pathways involved (JAK/STAT, PI3K/Akt).
Main Results:
- IL-34 induced monocytic-like differentiation in U937, HL-60, and THP-1 cell lines.
- Morphological and functional evidence supported monocytic differentiation.
- Cell surface marker analysis showed changes consistent with myeloid maturation (e.g., increased CD14, CD68; decreased CD11b, CD71).
- Differentiated cells exhibited enhanced endocytosis and respiratory burst activities.
- IL-34 did not induce cell proliferation or growth.
- Differentiation was mediated through JAK/STAT and PI3K/Akt pathways.
Conclusions:
- IL-34 induces differentiation of human leukemia cell lines (U937, HL-60, THP-1) towards monocyte- and macrophage-like cells.
- This differentiation is characterized by specific morphological, functional, and cell surface marker changes.
- IL-34's mechanism involves JAK/STAT and PI3K/Akt signaling pathways.
- This study is the first to report IL-34's differentiation-inducing effects in human leukemic cells.
